Myrtelle Launches Commercial Manufacturing First-in-Class Gene Therapy

Myrtelle Launches Commercial-Stage Manufacturing of First-in-Class Gene Therapy for Canavan Disease.

Article Date
July 8, 2025

This article is featured on another website.

Go to article

Related posts

Browse all articles
March 25, 2026

The Rare Disease Conversation Is Getting Louder. Here’s Where Myrtelle Stands.

March 25, 2026

The Rare Disease Conversation Is Getting Louder. Here’s Where Myrtelle Stands.

April 3, 2026

Winning in Biosimilars: Speed, Scale, and the New Competitive Playbook

April 3, 2026

Winning in Biosimilars: Speed, Scale, and the New Competitive Playbook